News-Medical.Net October 8, 2025
DNAnexus, Inc.

In this interview, NewsMedical speaks with Nripesh Prasad, Vice President of Scientific and Technical Development in Genomics at Discovery Life Sciences, about the organization’s transition to a cloud-based platform for managing and scaling its genomics operations.

Please introduce yourself and your role at Discovery Life Sciences.

My name is Nripesh Prasad, and I serve as the Vice President of Scientific and Technical Development in Genomics at Discovery Life Sciences. I oversee assay development, technology validation, qualification, and evaluation. I get to work on all the exciting parts, exploring and implementing new technologies across our services and ensuring we deliver innovative and high-quality solutions to our clients.

What makes Discovery Life Sciences unique in the life sciences ecosystem?

Discovery Life...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: Biotechnology, Cloud, Interview / Q&A, Pharma / Biotech, Technology, Trends
Related Articles:
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
Introducing the Sunday Times Tech 100: Life sciences part 1
China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says

Share Article